0001104659-24-033963.txt : 20240313
0001104659-24-033963.hdr.sgml : 20240313
20240313163339
ACCESSION NUMBER: 0001104659-24-033963
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240311
FILED AS OF DATE: 20240313
DATE AS OF CHANGE: 20240313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller Steven Clive
CENTRAL INDEX KEY: 0001883325
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40825
FILM NUMBER: 24746433
MAIL ADDRESS:
STREET 1: C/O WARBY PARKER INC.
STREET 2: 233 SPRING STREET, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Warby Parker Inc.
CENTRAL INDEX KEY: 0001504776
STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 800423634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 233 SPRING STREET
STREET 2: 6TH FLOOR EAST
CITY: NEW YORK
STATE: NY
ZIP: 10013
BUSINESS PHONE: (646) 847-7215
MAIL ADDRESS:
STREET 1: 233 SPRING STREET
STREET 2: 6TH FLOOR EAST
CITY: NEW YORK
STATE: NY
ZIP: 10013
FORMER COMPANY:
FORMER CONFORMED NAME: JAND, Inc.
DATE OF NAME CHANGE: 20101102
4
1
tm248127-7_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-03-11
0
0001504776
Warby Parker Inc.
WRBY
0001883325
Miller Steven Clive
C/O WARBY PARKER INC.,
233 SPRING STREET, 6TH FLOOR EAST
NEW YORK
NY
10013
0
1
0
0
Chief Financial Officer
1
Class A Common Stock
2024-03-11
4
S
0
24225
11.98
D
166879
D
These share sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2023.
The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $11.81 to $12.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
/s/ Chris Utecht, Attorney-in-Fact
2024-03-13